IL18 and chronic obstructive pulmonary disease: Patients with COPD with high levels of IL-18, TGF-β, RANTES, and uPAR compared to healthy controls warrant examination for the appearance of depressive symptoms and therapeutic intervention for the prevention of depressive symptoms.